NNN REIT, Inc. Announces Third Quarter 2026 Results
NNN REIT, Inc. (NYSE: NNN) (the "Company" or "NNN"), a real estate investment trust, today announced financial and operating results for the quarter…
Archive
400 releases
NNN REIT, Inc. (NYSE: NNN) (the "Company" or "NNN"), a real estate investment trust, today announced financial and operating results for the quarter…
Annualized total payment volume rose from US150 billion in one year. That works out to more than US$410 million processed through its infrastructure…
Small and mid-sized businesses with hourly, shift, and field teams can now offer attractive medical, dental, and vision coverage, with contributions…
As Anthropic approaches its anticipated IPO, questions surrounding valuation, competition and profitability are bringing the bearish investment case…
Creative Planning, LLC ("Creative Planning"), one of the nation's largest independent wealth management firms, today announced it has acquired…
IRSA Inversiones y Representaciones S.A. (NYSE: IRS; BYMA: IRSA), the leading real estate company in Argentina, announces today its results for the…
Key Takeaways: Montway has appointed Ahsan Rahim as CEO to lead the company's next phase of growth, bringing more than 25 years of leadership…
FISCAL 2027 FIRST QUARTER RESULTS
Budget Navigator pairs practical budgeting education with guidance inside Martus; expanded AI capabilities help teams answer financial and software…
Return on Average Equity climbs to 15.5% in Q3
XPEL Reports Revenue of $137.8 million; Revenue Growth of 9.9% in Third Quarter 2026
Peabody (NYSE: BTU) announced today that its Board of Directors has declared a quarterly dividend on its common stock of $0.075 per share, payable on…
•Biologics License Application for sonelokimab submitted to the U.S. Food and Drug Administration for the treatment of adults and adolescents with…
Northwestern Mutual's Personal Prosperity Index climbs to 71 out of 100 – three points higher than mid-year American Resiliency: Prosperity improves…
-- Multiple New Business Wins Continue to Strengthen Growing Pipeline --
Positive topline results from Phase 2 trial of RAP-219 in bipolar mania; initiation of two Phase 3 trials in bipolar mania expected in 2H 2027